02-Dec-15 Hua Xia Healthcare has declared plans to spend CNY1.2 bn (USD187 mn) acquiring a target company managing and operating eight hospitals in China. [image: ACN Newswire]

19-Nov-15 Private hospital group Healthscope has acquired the 83-bed Hunter Valley Private Hospital in New South Wales for $71.3 million. After the acquisition, Healthscope will operate 46 hospitals throughout Australia. [image: Patrick Scala]

16-Nov-15 Japan, with sales of USD115, accounts for 10% of the global pharma market, compared with 38% for the US and 21% for Europe. Lupin is the only Indian company in Japan's generics market. But now Sun Pharmaceuticals is planning to acquire Novartis' Japanese drug portfolio. Other Indian generics makers, including Dr Reddy’s and Glenmark, are also exploring options. [image: Bloomberg]

03-Nov-15 In the first quarter after its merger, Zimmer Biomet has reported it expects to complete commercial integration by the end of 2015. It also reported progress on its sales channel integration, evidenced by sequential sales improvement in its Asia-Pacific and Europe, Middle East & Africa (EMEA) regions, where Knee orthopaedics sales increased 9% and 6% respectively. [image: Zimmer Biomet]

03-Nov-15 Chinese diabetes tech firm Sinocare has signed an agreement to acquire Nipro Diagnostics from Japan's Nipro Corp, for USD273 mn. Nipro Diagnostics is based in Florida and manufacturers products for people with diabetes, including a portfolio of blood glucose monitoring technologies. Sinocare CEO Shaobo Li said “Diabetes has become one of the biggest challenges to our public healthcare system and society." [image: Sinocare]